Matthew D. Robson

Matthew Robson
FREng
Born
Matthew David Robson
Alma materUniversity of Cambridge
Known forQuantitative MRI, medical imaging technologies
Scientific career
FieldsMagnetic resonance imaging, medical imaging, image analysis, data science
InstitutionsUniversity of Oxford
Thesis Automated Analysis of MR Images  (1994)

Matthew David Robson is a British engineer, academic, and technology executive specializing in magnetic resonance imaging (MRI), medical imaging, and quantitative image analysis. He is currently the Chief Technology Officer and a co-founder of Perspectum, and was formerly a Professor of MR Physics at the University of Oxford. He was elected a Fellow of the Royal Academy of Engineering in 2024.

Career

Robson began his career as a postdoctoral researcher at Yale University before moving into industry roles in medical imaging.[1]

From 2001, Robson worked at the Oxford Centre for Clinical Magnetic Resonance Research at the University of Oxford.[2] He served as a research physicist and later as a university research lecturer. From 2014 to 2017, he was professor and director of MR physics at the Oxford Centre for Clinical Magnetic Resonance Research, where his responsibilities included MRI methods development and work on clinical research MRI systems at 1.5T, 3T, and 7T.[3]

In 2012, Robson co-founded Perspectum with Stefan Neubauer, Rajarshi Banerjee, and Michael Brady.[4] He has served as chief technology officer since 2017.[5]

Robson was elected a Fellow of the Royal Academy of Engineering in 2024.[1]

Research

Robson's research has focused on magnetic resonance imaging (MRI), with emphasis on quantitative imaging, cardiac magnetic resonance imaging, medical image analysis, and MRI-derived biomarkers. His early research included work on functional magnetic resonance imaging and ultrafast imaging methods at the Yale School of Medicine.[1]

At the University of Oxford, Robson worked on cardiovascular magnetic resonance imaging, including cardiac imaging at 3 Tesla, myocardial T1 mapping, and magnetic resonance spectroscopy.[1] He was involved in research on Shortened Modified Look-Locker Inversion Recovery (ShMOLLI), a method used for myocardial T1 mapping during a short breath-hold.[6] His work has also examined myocardial T1 measurement and the effects of magnetization transfer on cardiac MRI sequences.[7]

Robson has contributed to research on cardiac phosphorus-31 magnetic resonance spectroscopy, including studies comparing cardiac spectroscopy at 1.5T and 3T and later work on human cardiac spectroscopy at 7T.[8][9] He has also contributed to book chapters on the principles and methods of cardiovascular magnetic resonance.[10]

Robson has worked on ultrashort echo time (UTE) MRI, which is used to image tissues with very short T2 relaxation times, such as bone and connective tissue. He co-authored studies on phosphorus imaging of cortical and trabecular bone, cortical bone imaging using UTE pulse sequences, and clinical applications of UTE imaging.[11][12][13] He also co-authored a chapter on phase-contrast UTE imaging of very fast flows.[14]

His research has included quantitative MRI methods for vascular imaging and atherosclerosis assessment. He was a co-author of a study on in-vivo quantitative T2 mapping of carotid arteries in patients with atherosclerosis, which examined the use of T2 maps for plaque classification and measurement of plaque components.[15]

His later work has included quantitative MRI methods for liver disease assessment. He was a co-author of a 2014 study in the Journal of Hepatology on multiparametric magnetic resonance imaging for the non-invasive assessment of liver disease.[16] A later study examined the use of multiparametric MRI in patients with chronic liver disease and its association with clinical outcomes.[17]

References

  1. ^ a b c d "Professor Matthew Robson FREng". Royal Academy of Engineering.
  2. ^ "Neubauer Group: Oxford Centre for Clinical Magnetic Resonance Research". Radcliffe Department of Medicine.
  3. ^ "Contacts for Imaging | NIHR Biomedical Research Centre". Oxford.
  4. ^ "Finding the silent killer". Oxford Mail. 17 April 2014.
  5. ^ "Perspectum". The Sunday Times. 16 January 2026.
  6. ^ Piechnik, Stefan K; Ferreira, Vanessa M; Dall'Armellina, Erica; Cochlin, Lowri E; Greiser, Andreas; Neubauer, Stefan; Robson, Matthew D (October 2010). "Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold". Journal of Cardiovascular Magnetic Resonance. 12 (1): 69. doi:10.1186/1532-429X-12-69. PMC 3001433. PMID 21092095.
  7. ^ Robson, Matthew D.; Piechnik, Stefan K.; Tunnicliffe, Elizabeth M.; Neubauer, Stefan (2013). "T1 measurements in the human myocardium: the effects of magnetization transfer on the SASHA and MOLLI sequences". Magnetic Resonance in Medicine. 70 (3): 664–670. doi:10.1002/mrm.24867. PMID 23857710.
  8. ^ Tyler, Damian J.; Hudsmith, Lucy E.; Clarke, Kieran; Neubauer, Stefan; Robson, Matthew D. (2008). "A comparison of cardiac 31P MRS at 1.5 and 3 T". NMR in Biomedicine. 21 (8): 793–798. doi:10.1002/nbm.1255. PMID 18512846.
  9. ^ Rodgers, Christopher T.; Clarke, William T.; Snyder, Curtis; Vaughan, J. Thomas; Neubauer, Stefan; Robson, Matthew D. (2014). "Human cardiac 31P magnetic resonance spectroscopy at 7 tesla". Magnetic Resonance in Medicine. 72 (2): 304–315. doi:10.1002/mrm.24922. PMC 4106879. PMID 24006267.
  10. ^ Selvanayagam, Joseph; Robson, Matthew D.; Francis, Jane; Neubauer, Stefan (11 October 2010). "Basic Principles, Methods, and Techniques". Cardiac CT, PET and MR. Wiley-Blackwell. ISBN 978-1-4051-8553-0.
  11. ^ Robson, Matthew D.; Gatehouse, Peter D.; Bydder, Graeme M.; Neubauer, Stefan (2004). "Human imaging of phosphorus in cortical and trabecular bone in vivo". Magnetic Resonance in Medicine. 51 (5): 888–892. doi:10.1002/mrm.20055. PMID 15122669.
  12. ^ Reichert, Ines L. H.; Robson, Matthew D.; Gatehouse, Peter D.; He, Taigang; Chappell, Karyn E.; Holmes, Joanne; Girgis, Samia; Bydder, Graeme M. (2005). "Magnetic resonance imaging of cortical bone with ultrashort TE pulse sequences". Magnetic Resonance Imaging. 23 (5): 611–618. doi:10.1016/j.mri.2005.02.017. PMID 16051035.
  13. ^ Robson, Matthew D.; Bydder, Graeme M. (2006). "Clinical ultrashort echo time imaging of bone and other connective tissues". NMR in Biomedicine. 19 (7): 765–780. doi:10.1002/nbm.1100. PMID 17075960.
  14. ^ O'Brien, Kieran R.; Robson, Matthew D. (2012). "Imaging of Very Fast Flows with PC-UTE". Encyclopedia of Magnetic Resonance. John Wiley & Sons. pp. 521–528. doi:10.1002/9780470034590.emrstm1248. ISBN 978-0-470-03459-0.
  15. ^ Biasiolli, Luca; Lindsay, Alistair C.; Chai, Joshua T.; Choudhury, Robin P.; Robson, Matthew D. (2013). "In-vivo quantitative T2 mapping of carotid arteries in atherosclerotic patients: segmentation and T2 measurement of plaque components". Journal of Cardiovascular Magnetic Resonance. 15 (1) 69. doi:10.1186/1532-429X-15-69. PMC 3751854. PMID 23953780.
  16. ^ Banerjee, Rajarshi; Pavlides, Michael; Tunnicliffe, Elizabeth M.; Piechnik, Stefan K.; Sarania, Nikita; Philips, Rachel; Collier, Jane D.; Booth, Jonathan C.; Schneider, Jürgen E.; Wang, Lai Mun; Delaney, David W.; Fleming, Kenneth; Robson, Matthew D.; Barnes, Eleanor; Neubauer, Stefan (2014). "Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease". Journal of Hepatology. 60 (1): 69–77. doi:10.1016/j.jhep.2013.09.002. PMC 3865797. PMID 24036007.
  17. ^ Pavlides, Michael; Banerjee, Rajarshi; Tunnicliffe, Elizabeth M.; Kelly, Christopher; Collier, Jane; Booth, Jonathan; Houlston, Robert; Neubauer, Stefan; Barnes, Eleanor; Robson, Matthew D. (2016). "Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease". Journal of Hepatology. 64 (2): 308–315. doi:10.1016/j.jhep.2015.10.009. PMC 4751288. PMID 26471505.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.